CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $168.13M, lower than 95% of all stocks globally
- PositionReturn on equity is 19.3%, higher than 95% of its Medical Devices peers (median 3%)
- Interpretations9 currently firing — 9
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.29%
Annual Rate
KRW 208.00Paid quarterly
Payout Ratio
51.7%Sustainable
Payback Period
57.8 yr
Last Ex-Dividend
Dec 29, 2025
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
238.18BKRW168.13M · vs all stocks (USD)
Trailing P/E
25.32xvs Medical Devices peers
Revenue (TTM)
38.72BKRW27.34M · vs all stocks (USD)
Profit Margin
19.95%vs Medical Devices peers
52-Week Change
-44.18%vs all stocks
Forward Annual Dividend Yield
3.29%vs all stocks
Market Capitalization
238.18BKRW168.13M · vs all stocks (USD)
Enterprise Value
214.28BKRW151.26M · vs all stocks (USD)
Trailing P/E
25.32xvs Medical Devices peers
PEG Ratio
-0.0926xvs Medical Devices peers
Price to Sales (TTM)
5.98xvs Medical Devices peers
Price to Book (MRQ)
5.39xvs Medical Devices peers
Enterprise to Revenue
5.53xvs Medical Devices peers
Enterprise to EBITDA
21.65xvs Medical Devices peers
Gross Margin
77.28%vs Medical Devices peers
Profit Margin
19.95%vs Medical Devices peers
Operating Margin
-23.86%vs Medical Devices peers
Return on Assets (TTM)
10.62%vs Medical Devices peers
Return on Equity (TTM)
19.29%vs Medical Devices peers
Revenue (TTM)
38.72BKRW27.34M · vs all stocks (USD)
Revenue per Share (TTM)
1.04KKRWUpdated Jul 15, 2026Quarterly Revenue Growth
11.70%vs Medical Devices peers
Gross Profit (TTM)
30.48BKRW21.52M · vs all stocks (USD)
EBITDA (TTM)
12.52BKRW8.84M · vs all stocks (USD)
Net Income (TTM)
7.73BKRW5.45M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.67%vs Medical Devices peers
Operating Cash Flow (TTM)
2.16BKRW1.52M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-2.21BKRW-1.56M · vs all stocks (USD)
Forward Annual Dividend Rate
208.00KRWUpdated Jul 15, 2026Forward Annual Dividend Yield
3.29%vs all stocks
Trailing Annual Dividend Rate
106.00KRWUpdated Jul 15, 2026Trailing Annual Dividend Yield
1.67%vs all stocks
Payout Ratio
51.71%vs Medical Devices peers
Revenue
37.94BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
7.90BKRWFY2025 · Dec 31, 2025Gross Profit
30.04BKRWFY2025 · Dec 31, 2025Operating Income
10.39BKRW7.34M · vs all stocks (USD)
Pre-tax Income
10.78BKRWFY2025 · Dec 31, 2025Income Tax Expense
1.57BKRWFY2025 · Dec 31, 2025Net Income
9.21BKRWFY2025 · Dec 31, 2025EBIT
10.85BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
12.52BKRWFY2025 · Dec 31, 2025Research & Development
3.26BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
10.65BKRWFY2025 · Dec 31, 2025Other Operating Expenses
355.61MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
225.07MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
70.84MKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
9.21BKRWFY2025 · Dec 31, 2025Operating Cash Flow
1.36BKRWFY2025 · Dec 31, 2025Free Cash Flow
1.46MKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.91BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
9.21BKRWFY2025 · Dec 31, 2025Stock-based Compensation
22.86MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-154.23MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-4.66BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.06BKRWFY2025 · Dec 31, 2025Capital Expenditures
-1.36BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-56.49MKRWFY2025 · Dec 31, 2025Purchase of Investments
-20.89BKRWFY2025 · Dec 31, 2025Sale of Investments
2.74BKRWFY2025 · Dec 31, 2025Other Investing Activity
10.00KRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-19.51BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-3.07BKRWFY2025 · Dec 31, 2025Other Financing Charges
-731.35MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
16.47BKRWFY2025 · Dec 31, 2025Shares Outstanding
37.63MSharesUpdated Jul 15, 2026Float Shares
18.42MSharesUpdated Jul 15, 2026% Held by Insiders
46.97%vs all stocks
% Held by Institutions
0.35%vs all stocks
Total Cash (MRQ)
18.86BKRW13.31M · vs all stocks (USD)
Total Cash per Share (MRQ)
501.29KRWUpdated Jul 15, 2026Total Debt (MRQ)
1.74BKRW1.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0393xvs Medical Devices peers
Current Ratio (MRQ)
5.51xvs Medical Devices peers
Book Value per Share (MRQ)
1.18KKRWUpdated Jul 15, 2026Total Assets
52.21BKRW36.86M · vs all stocks (USD)
Total Current Assets
46.18BKRWFY2025 · Dec 31, 2025Total Liabilities
5.45BKRWFY2025 · Dec 31, 2025Total Non-current Assets
6.03BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
184.24MKRWFY2025 · Dec 31, 2025Total Current Liabilities
5.26BKRWFY2025 · Dec 31, 2025Cash
744.00KKRWFY2025 · Dec 31, 2025Cash Equivalents
6.90BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
6.91BKRWFY2025 · Dec 31, 2025Other Short-term Investments
18.61BKRWFY2025 · Dec 31, 2025Accounts Receivable
11.95BKRWFY2025 · Dec 31, 2025Inventory
6.58BKRWFY2025 · Dec 31, 2025Accounts Payable
981.02MKRWFY2025 · Dec 31, 2025Short-term Debt
1.63BKRWFY2025 · Dec 31, 2025Other Current Liabilities
172.31MKRWFY2025 · Dec 31, 2025Long-term Debt
99.24MKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
200.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
3.75BKRWFY2025 · Dec 31, 2025Retained Earnings
14.55BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
46.76BKRW33.01M · vs all stocks (USD)
52-Week Low
5.60KKRWUpdated Jul 15, 202652-Week High
17.48KKRWUpdated Jul 15, 202652-Week Change
-44.18%vs all stocks
50-Day MA
8.41KKRWUpdated Jul 15, 2026200-Day MA
11.88KKRWUpdated Jul 15, 2026Avg 10-Day Volume
33.82KSharesUpdated Jul 15, 2026Avg 30-Day Volume
53.70KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
246.00KRWUpdated Jul 15, 20269 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 19.3%, higher than 95% of its Medical Devices peers (median 3%)Significant
Return on equity: 0.19Industry median: 0.03Industry P95: 0.17Peers compared: 102
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 5,454,477.418Operating Cash Flow (USD, TTM): 1,521,924.014
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $168.13M, lower than 95% of all stocks globallySignificant
Market cap (USD): 168,133,137.83Global P5: 269,387,740.27
Revenue is $27.34M, lower than 95% of all stocks globallySignificant
Revenue (USD): 27,335,645.851Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
ADC Therapeutics S.A.
Tier 1ProductionApproval-Gated PipelineRule
Alector Inc.
Tier 1ProductionApproval-Gated PipelineRule
Journey Medical Corp
Tier 1ProductionApproval-Gated PipelineRule
Mycenax Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sensorion SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Graphy Inc.
Tier 1ProductionApproval-Gated PipelineRule
NervGen Pharma Corp.
Tier 1ProductionApproval-Gated PipelineRule
Chill Brands Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
MediWound Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Argosy Research Inc.
7 interpretationsROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And EquityMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Intuitive Surgical, Inc.
6 interpretationsROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity
Amoy Diagnostics Co., Ltd.
6 interpretationsROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Book ValuePrice Below Mean With Profitability And Equity